T/CACM 1061-2018 Drug Economic Evaluation Report Quality Assessment Guidelines

Scope

Main technical content: Pharmacoeconomic evaluation can effectively improve and enhance the allocation and utilization efficiency of drug resources, and has received increasing attention from more and more countries and regions, with its application becoming increasingly widespread. Although the research and application of pharmacoeconomics have a history of several decades worldwide, its development in China started relatively late, and there are still some problems in research quality, urgently requiring further evaluation and standardization of pharmacoeconomic research quality. At present, more than 20 countries have promulgated "Pharmacoeconomic Evaluation Guidelines", and some institutions or scholars have developed different types of "economic research quality evaluation guidelines" to standardize pharmacoeconomic research. However, the scope of application of different guidelines is inconsistent, the quality evaluation standards are difficult to unify, and the evaluation results are difficult to quantify. Therefore, it is very necessary to develop a comprehensive and objective pharmacoeconomic evaluation quality assessment guideline with quantifiable results. At present, only the "Chinese Pharmacoeconomic Evaluation Guidelines (2015 Edition)" in China standardize Chinese pharmacoeconomic research. This guideline is a methodological guide for pharmacoeconomic evaluation and a general norm for evaluating pharmacoeconomics, but there is no corresponding quality evaluation guideline for the process and results of pharmacoeconomic evaluation. To standardize the reporting of pharmacoeconomic evaluations and determine the quality of the process and reports of pharmacoeconomic research, the "Pharmacoeconomic Evaluation Report Quality Assessment Guidelines" (PEERs) have been developed. PEERs refer to international reporting norms to set standards, and study existing authoritative health technology evaluation quality scales including the Quality of Health Economics Re

Development Information

Related Standards